Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guipi Anshuiyin is a Traditional Chinese Medicine (TCM) formulation developed by the Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang) for the treatment of chronic insomnia. The formula is specifically designed for patients exhibiting the "Heart and Spleen Deficiency" pattern, a common TCM diagnosis for sleep disorders. It is derived from the classical *Guipi Tang* (Spleen-Restoring Decoction) and incorporates additional herbs to enhance its sedative and "spirit-calming" (An Shen) properties. The mechanism of action involves the synergistic effect of multiple botanical compounds that are thought to modulate the central nervous system, potentially through the GABAergic and serotonergic pathways, to improve sleep architecture, reduce sleep latency, and alleviate daytime fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guipi Anshuiyin.